A Wall Street Journal investigation finds that weak regulation and safety standards are allowing Americans to self-administer ketamine in their homes, sometimes with fatal consequences.
Host Indira Lakshmanan speaks to reporter Shalini Ramachandran.
This article was originally published on WBUR.org.
Copyright 2026 WBUR
